NeoGenomics, Inc. (NEO)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$8.97
+4.17%
Mkt Cap $224.11M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (18 analysts)
$13.50
Range $13.00 – $14.00
Implied Upside
+50.5%
Consensus $13.50 vs current $8.97